Archive for ‘October, 2009’
Written by Michael Vlaicu
Daily Profiles
Oct 27, 2009
W2 ENERGY, Inc.
(PINK:WTWO.PK)
MiV Investments initiates an independent company profile on W2 Energy, Inc. (PINK:WTWO.PK), which looks to breakthrough within a $23B bio-fuel industry, as a successful alternative renewable energy company amongst worldwide rising oil and energy prices. since the dawn of technological advancements, the world has relied on the burning of fossil fuels in order [...]
Written by Michael Vlaicu
Daily Profiles
Oct 26, 2009
BioCurex Inc
(Public, OTC:BOCX)
http://www.biocurex.com/
BioCurex, Inc. (“BioCurex” or “the Company”) is a biotechnology company developing products for cancerdiagnosis, imaging, and therapy that target a global oncology market forecast to reach over $50 billion by 2009. The Company uses a novel, patented technology based on the RECAF™ cancer marker, discovered by Dr. Ricardo Moro-Vidal, BioCurex’s chief executive officer [...]
Written by Michael Vlaicu
Daily Profiles
Oct 22, 2009
Diverse Media Group Inc.
(Public, PINK:DVME.PK)
MiV Investments profiles Diverse Media Group (PINK:DVME.PK) which has recently made a 50% acquisition of Celebrities in Action, Inc. which has a joint venture with Stan Lee, and has agreed to sign up for the responsibilities in regards to finding high profile celebrities and athletes for their movie roles. It is [...]
Written by Michael Vlaicu
Daily Profiles, World News
Oct 20, 2009
XTEND MEDICAL CORP
(Public, PINK:XMDC)
Cancer has quickly become one of the deadliest diseases, causing well over 13% of all human deaths. Cancer rates could further increase by 50% to 15 million new cases in the year 2020, according to the World Cancer Report, the most comprehensive global examination of the disease to date. Due to this [...]
Written by Michael Vlaicu
Daily Profiles, World News
Oct 16, 2009
BizAuctions Inc.
(Public, PINK:BZCN.PK)
As the holiday season fast approaches during one of the most hard hit economic times in recent memory, certain discount companies look to profit and gain recognition, differentiating themselves from the pack. One of these such companies is BizAuctions Inc. (PINK:BZCN.PK), which is quickly gaining momentum in a $60B excess inventory liquidation market. [...]
Written by Michael Vlaicu
Daily Profiles
Oct 14, 2009
AVAX Technologies, Inc.
(Public, OTC:AVXT.PK)
AVAX Technologies, Inc. has gone through a vast number of ups and downs throughout 2006 to 2007. At this time StocksHaven Investments profiles the company and takes look at what investors may expect within the near future.
AVAX had a number of expectations to meet in order to sustain ongoing business operations: equity [...]
Written by Michael Vlaicu
Daily Profiles
Oct 13, 2009
Paradigm Medical Industries, Inc.
(Public, OTC:PDMI.PK)
The Medical device industry has been one of the most successful industries within 2008 and 2009, and 2010 should continue that trend. StocksHaven Investments profiles Paradigm Medical Industries, Inc., a promising company who will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the [...]
Written by Michael Vlaicu
Daily Profiles
Oct 8, 2009
Guided Therapeutics, Inc.
(Public, OTC:GTHP)
Guided Therapeutics, Inc. (OTC:GTHP) contains perhaps one of the most promising medical devices aiming for an annual global $1 billion dollar non-invasive cervical cancer market. Now, lets take a look at how it sits alongside the likes of Nephros (OTC:NEPH) and Imaging3 (OTC:IMGG). Their device LightTouch is a powerful and innovative non-invasive [...]
Written by Michael Vlaicu
Conferences, Daily Profiles
Oct 6, 2009
Soligenix, Inc.
(Public, OTC:SNGX)
Soligenix truly is a magnificent company, its no wonder the government also favours it so much by pouring in grants and funding. It stands tall amongst the other struggling small cap biotechs, and even after changing its company info from DORB Pharma (OTC:DORB.OB) to Soligenix (OTC:SNGX.OB), it remains ahead of the pack while [...]
Written by Michael Vlaicu
Daily Profiles
Oct 2, 2009
Soligenix, Inc.
(Public, OTC:SNGX)
The past year and a half has come to be known as the rise of the small cap biotechs — Anyone want to contact Steven Spielberg for a movie suggestion? Terminator: Rise of the Machines, oh please. Nothing seems to stand in the way of these once forgotten ghosts, as they are now [...]